- Home
- AMLX vs ACHC Comparison
AMLX vs ACHC Comparison
Compare AMLX & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | ACHC |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AMLX | ACHC |
|---|---|---|
| Price | $17.78 | $30.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 15 |
| Target Price | $21.56 | ★ $22.67 |
| AVG Volume (30 Days) | 1.7M | ★ 3.1M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $380,786,000.00 | ★ $3,312,769,000.00 |
| Revenue This Year | N/A | $5.08 |
| Revenue Next Year | N/A | $5.98 |
| P/E Ratio | ★ N/A | $638.40 |
| Revenue Growth | ★ 1612.94 | 5.04 |
| 52 Week Low | $7.48 | $11.43 |
| 52 Week High | $19.15 | $32.82 |
Technical Indicators
Market Signals| Indicator | AMLX | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 63.29 | 64.16 |
| Support Level | $12.17 | $22.52 |
| Resistance Level | $18.88 | N/A |
| Average True Range (ATR) | 1.02 | 1.44 |
| MACD | 0.13 | 0.61 |
| Stochastic Oscillator | 67.64 | 76.52 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.